Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

NCT00892775 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00892775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00892775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2009
Completion date
December 13, 2010
Enrollment
501 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

measles, mumps, rubella, varicella